Targeting tumor-associated macrophages in gastric cancer progression and therapy: insights from molecular mechanisms to therapeutic applications
Frontiers in Pharmacology · 17.06.2025 · 16
DOI: 10.3389/fphar.2025.1549694 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.06.2025. Verfasst von ChengTao Wan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Jian Yang Hospital of Traditional Chinese Medicine, Chengdu, Sichuan, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gastric cancer (GC) is the fifth most common malignant tumor that imposes heavily public health burdens worldwide. Systemic therapies for gastric cancer (GC), such as chemotherapy, targeted therapy, and immunotherapy, have undergone significant advancements. Nevertheless, the extensive application of anti-cancer agents has resulted in an increasing array of challenges related to drug resistance, presenting a substantial barrier in GC treatment. Tumor-associated macrophages (TAMs) as essential immunomodulators within the tumor immune microenvironment (TIME) of GC, providing novel therapeutic targets due to their capacity for plasticity in reaction to environmental signals. They create a complex network of communication with various immune and stromal cell types, thereby contributing to the immunosuppressive nature of the TME in GC. In this review, we establish the map of the origin and polarization of macrophages in GC. During the process of carcinogenesis, macrophages undergo dynamic phenotypic transitions. Additionally, the interactions between TAMs and tumor cells significantly influence the progression of GC, affecting tumor growth, metastasis, angiogenesis, and drug resistance. Furthermore, this intricate immunomodulatory axis notably enhances resistance to immunotherapy, suggesting that targeting TAMs presents substantial therapeutic opportunities for patients with GC. Approaches such as TAM elimination, TAM repolarization, and CAR-M therapy have been validated in numerous studies. We also elaborate on the challenges faced by the development of targeting TAMs, which may provide innovative perspectives on the GC treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Jian Yang Hospital of Traditional Chinese Medicine, Chengdu, Sichuan, China.
- The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
- School of Sports Medicine and Health, Chengdu Sport University, Chengdu, Sichuan, China.
- Department of Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Zitieren
APA
Wan, C., Deng, J., Zhu, Y., Wan, L., Xu, L., Chen, Q., Zou, C., & Huang, J. (2025). Targeting tumor-associated macrophages in gastric cancer progression and therapy: insights from molecular mechanisms to therapeutic applications. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1549694
Vancouver
Wan C, Deng J, Zhu Y, Wan L, Xu L, Chen Q, et al. Targeting tumor-associated macrophages in gastric cancer progression and therapy: insights from molecular mechanisms to therapeutic applications. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1549694
BibTeX
@article{Wan2025,
author = {Wan, ChengTao and Deng, Jie and Zhu, Yu and Wan, Li and Xu, Linyue and Chen, Qiuyan and Zou, Can and Huang, Ju},
title = {Targeting tumor-associated macrophages in gastric cancer progression and therapy: insights from molecular mechanisms to therapeutic applications},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1549694}
}
EUVIMED